A new study discovers molecular pathways that could lead to new targeted therapies which may potentially treat Glioblastoma, the most common and lethal form of brain cancer in adults.
Understanding glioblastoma at the genetic, molecular level Glioblastoma is the most common and most lethal form of brain tumor in...
A small molecule, 6-thio-dG, may provide a new approach to treating currently untreatable pediatric brain cancers, researchers report.
Trifluoperazine, a dopamine receptor antagonist commonly prescribed for schizophrenia, used in combination with radiation therapy delays the growth of glioblastoma brain tumors and prolongs survival for brain cancer.
By altering DON, an anti-cancer drug cultivated from bacteria originally found in Peruvian soil over 70 years ago, scientists believe they have made a safer and more tolerable form of the drug.
Scientists at the Keck School of Medicine of USC grow brain cells from skin Oncogenes are generally thought to be...
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.
Researchers discovered a mutant form of Chk1 gene that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs. This study illustrates an unprecedented finding, that artificially activating Chk1 alone is sufficient to kill cancer cells.
Researchers have successfully bypassed the blood-brain barrier using a laser probe to help deliver chemotherapy drugs to glioblastoma patients.